Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00375089 · ClinicalTrials.gov registry record
Characteristics of Prader-Willi Syndrome and Early-onset Morbid Obesity
A clinical trial, sponsored by University of Florida.
- Completed
- Registry status
- 392
- Enrollment target
NCT00375089 is a clinical trial that has completed, run by University of Florida. The registered enrollment target is 392 participants.
The verdict
NCT00375089 has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- 392 participants
- Enrollment target
Study Summary
Prader-Willi syndrome (PWS) is a rare genetic disorder that affects about 1 in 14,000 people in the United States. As the most commonly identified genetic cause of obesity, PWS is often confused with Early-onset Morbid Obesity (EMO). Individuals with EMO show some signs of PWS, but clinically do not have PWS. The purpose of this study is to evaluate the clinical features and genetic basis of PWS and EMO, and to determine how these conditions affect a person throughout a lifetime.
Interventions
- OTHER Group 1
- OTHER Group 2
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 392 participants |
| Start Date | 2006-09 |
| Est. Completion | 2014-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00375089
The ClinicalTrials.gov registry entry for NCT00375089 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 392 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Group 1 is the first listed.
NCT00375089 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00375089 about?
NCT00375089 is a clinical study titled "Characteristics of Prader-Willi Syndrome and Early-onset Morbid Obesity". Prader-Willi syndrome (PWS) is a rare genetic disorder that affects about 1 in 14,000 people in the United States. As the most commonly identified genetic cause of obesity, PWS is often confused with Early-onset Morbid Obesity (EMO). Individuals with EMO show some signs of PWS, but clinically do not...
What is the current status of trial NCT00375089?
This trial is currently completed. The enrollment target is 392 participants. The study started on 2006-09. Estimated completion is 2014-01.
What interventions are being tested in trial NCT00375089?
The interventions under investigation include: Group 1 (OTHER), Group 2 (OTHER).
Who is sponsoring clinical trial NCT00375089?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.